BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31365601)

  • 1. Left Atrial Appendage Transcatheter Occlusion with AMPLATZER™ Amulet™ Device: Real Life Data with Mid-Term Follow-Up Results.
    Şahiner ML; Kaya EB; Çöteli C; Aytemir K
    Arq Bras Cardiol; 2019; 113(4):712-721. PubMed ID: 31365601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.
    Jalal Z; Iriart X; Dinet ML; Selly JB; Tafer N; Renou P; Sibon I; Thambo JB
    Arch Cardiovasc Dis; 2016 Dec; 109(12):659-666. PubMed ID: 27402154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage occlusion: initial experience with the Amplatzer™ Amulet™.
    Freixa X; Abualsaud A; Chan J; Nosair M; Tzikas A; Garceau P; Basmadjian A; Ibrahim R
    Int J Cardiol; 2014 Jul; 174(3):492-6. PubMed ID: 24820753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
    Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
    Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-free, echocardiography-guided left atrial appendage occlusion (LAAo): a propensity-matched comparison with conventional LAAo using the AMPLATZER™ Amulet™ device.
    Sedaghat A; Al-Kassou B; Vij V; Nelles D; Stuhr M; Schueler R; Omran H; Schrickel JW; Hammerstingl C; Nickenig G
    Clin Res Cardiol; 2019 Mar; 108(3):333-340. PubMed ID: 30536045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation.
    Pepe M; Suppressa P; Giuliano AF; Nestola PL; Bortone AS; DE Cillis E; Acquaviva T; Forleo C; Moscarelli M; Lenato GM; Sabbà C
    Minerva Cardiol Angiol; 2022 Oct; 70(5):537-544. PubMed ID: 33703853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Atrial Appendage Occlusion in Patients With Thrombus in Left Atrial Appendage.
    Sahiner L; Coteli C; Kaya EB; Ates A; Kilic GS; Yorgun H; Aytemir K
    J Invasive Cardiol; 2020 Jun; 32(6):222-227. PubMed ID: 32330118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study.
    Hildick-Smith D; Landmesser U; Camm AJ; Diener HC; Paul V; Schmidt B; Settergren M; Teiger E; Nielsen-Kudsk JE; Tondo C
    Eur Heart J; 2020 Aug; 41(30):2894-2901. PubMed ID: 32243499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic migration of an AMPLATZER™ Amulet™ left atrial appendage occluder through the mitral valve.
    Mester P; Dompnier A; Belle L
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):346-349. PubMed ID: 27143657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y
    Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.
    Urena M; Rodés-Cabau J; Freixa X; Saw J; Webb JG; Freeman M; Horlick E; Osten M; Chan A; Marquis JF; Champagne J; Ibrahim R
    J Am Coll Cardiol; 2013 Jul; 62(2):96-102. PubMed ID: 23665098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion.
    Berte B; Jost CA; Maurer D; Fäh-Gunz A; Pillois X; Naegeli B; Pfyffer M; Sütsch G; Scharf C
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1140-1150. PubMed ID: 28675629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
    Price MJ; Ellis CR; Nielsen-Kudsk JE; Thaler D; Gupta N; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2127-2138. PubMed ID: 36357016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.